Immunogenomic Profiling Reveals a Suppressive Tumor Microenvironment and Immune Evasion Signatures In Glioblastoma
Glioblastoma (GBM) is an aggressive brain tumor known for its poor prognosis and resistance to immunotherapy, largely due to a pro-foundly immunosuppressive tumor microenvironment. Understanding the immunogenomic landscape of GBM is critical for identifying biomarkers and therapeutic targets. Transcriptomic data from...